Alaunos Therapeutics Inc.
TCRT | NASDAQ
$1.26
+$0.06 (+5.00%)
At close: Sep 21, 2026, 4:00 PM ET
$1.22
-$0.04 (-3.17%)
Pre-market:
Sep 22, 2026, 8:24 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -4.01M | -4.11M | -4.18M | -4.03M | -3.99M | -4.07M | -4.68M | -11.78M | -19.13M | -26.77M | -35.14M | -36.46M | -36.83M | -37.99M | -37.73M | -40.37M | -54.25M | -66.99M | -78.75M | -89.73M | -87.31M | -83.24M |
Depreciation & Amortization | 24K | 15K | 7K | -1K | -1K | n/a | 2K | 244K | 923K | 1.62M | 2.32M | 2.77M | 2.78M | 2.77M | 2.76M | 2.77M | 2.75M | 2.75M | 2.6M | 2.31M | 1.96M | 1.53M |
Stock-Based Compensation | 275K | 402K | 414K | 460K | 413K | 331K | 435K | 604K | 1.25M | 2.06M | 2.8M | 3.43M | 3.51M | 3.59M | 3.53M | 3.57M | 5.13M | 9.43M | 10.77M | 11.29M | 10.71M | 7.09M |
Other Working Capital | 302K | 494K | 374K | 66K | 258K | -320K | -625K | -2.68M | -3.37M | -4.46M | -5.48M | -5.72M | -5.84M | -7.51M | -5.05M | -8.88M | -5.06M | -660K | -511K | 3.31M | 738K | 1.51M |
Other Non-Cash Items | 879K | 498K | 413K | 205K | 31K | 1K | 1K | 2.69M | 3.07M | 4.53M | 5.11M | 2.89M | 2.85M | 3.66M | 3.27M | 3.78M | 3.78M | 792K | 594K | 68.59M | 68.25M | 68.97M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.01M | 1.02M | 1.02M | 1.02M | 10K | n/a | n/a | n/a | n/a | n/a | n/a | -68.97M | -68.97M | -68.97M |
Change in Working Capital | 105K | 66K | 473K | 452K | 704K | -87K | -729K | -3.52M | -4.49M | -5.14M | -6.25M | -3.54M | -1.97M | -2.86M | -1.06M | -6.98M | 1.92M | 92K | 3.32M | 13.13M | 5.5M | 12.21M |
Operating Cash Flow | -2.73M | -3.13M | -2.87M | -2.91M | -2.85M | -3.83M | -4.97M | -11.76M | -17.36M | -22.68M | -30.14M | -29.89M | -29.66M | -30.84M | -29.23M | -37.23M | -40.66M | -53.93M | -61.47M | -63.38M | -69.87M | -62.42M |
Capital Expenditures | -98K | -98K | -98K | -97K | n/a | n/a | n/a | n/a | -1K | -136K | -197K | -313K | -326K | -248K | -216K | -459K | -815K | -2.64M | -3.32M | -6.73M | -8.37M | -9.98M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.5M | 1.51M | 1.51M | 1.51M | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 38K | 61K | 61K | 61K | 23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -98K | -98K | -98K | -97K | n/a | n/a | n/a | 1.5M | 1.5M | 1.37M | 1.35M | -250K | -265K | -187K | -193K | -459K | -815K | -2.64M | -3.32M | -6.73M | -8.37M | -9.98M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 125K | 125K | -11.73M | -17.98M | -24.36M | -26.44M | -14.58M | -8.33M | -2.27M | 24.74M | 24.74M | 24.74M | 24.93M | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -45K | -45K | -45K | -45K | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 70K | n/a | n/a | n/a | n/a | n/a | n/a | -125K | -125K | -250K | -250K | -125K | -104K | 21K | 21K | 21K | n/a | n/a | n/a | 399K | 426K | 438K |
Financial Cash Flow | 70K | 3.26M | 3.26M | 3.26M | 3.26M | n/a | n/a | n/a | n/a | -11.98M | -18.14M | -9.66M | -11.77M | 209K | 6.37M | -2.29M | 24.74M | 24.76M | 25.78M | 26.36M | 1.46M | 1.46M |
Net Cash Flow | -2.76M | 35K | 294K | 255K | 416K | -3.83M | -4.97M | -10.26M | -15.85M | -33.29M | -46.93M | -39.8M | -41.69M | -30.82M | -23.06M | -39.98M | -16.74M | -31.8M | -39.02M | -43.75M | -76.78M | -70.95M |
Free Cash Flow | -2.82M | -3.23M | -2.97M | -3.01M | -2.85M | -3.83M | -4.97M | -11.76M | -17.36M | -22.81M | -30.34M | -30.2M | -29.98M | -31.09M | -29.45M | -37.69M | -41.48M | -56.56M | -64.79M | -70.11M | -78.24M | -72.4M |
Adj. Free Cash Flow | -3.1M | -3.63M | -3.38M | -3.47M | -3.26M | -4.16M | -5.41M | -12.37M | -18.61M | -24.88M | -33.14M | -33.63M | -33.49M | -34.68M | -32.98M | -41.26M | -46.61M | -65.99M | -75.57M | -81.4M | -88.95M | -79.49M |
Maintenance CapEx | -98K | -98K | -98K | -97K | n/a | n/a | n/a | n/a | -1K | -117.12K | -178.12K | -262.95K | -261.95K | -202.83K | -170.83K | -445K | -445K | -2.27M | -2.95M | -6.36M | -8.37M | -9.98M |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -18.88K | -18.88K | -50.05K | -64.05K | -45.17K | -45.17K | -14K | -370K | -370K | -370K | -370K | n/a | n/a |
Owner Earnings | -2.82M | -3.23M | -2.97M | -3.01M | -2.85M | -3.83M | -4.97M | -11.76M | -17.36M | -22.8M | -30.32M | -30.15M | -29.92M | -31.05M | -29.4M | -37.67M | -41.11M | -56.19M | -64.42M | -69.74M | -78.24M | -72.4M |
Add to Watchlist
Select watchlists to add or remove TCRT